Skip to main content
OpenTrials

Clinical trial condition

Neuroinflammatory Diseases

Explore clinical trials studying Neuroinflammatory Diseases. Study availability and eligibility vary by location and protocol.

1,038 public trials 116 recruiting studies
Refine in advanced search Browse all conditions

Neuroinflammatory Diseases trial results

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers

NCT02955797

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Investigational Site 309 Espoo, Finland
  • Investigational Site 301 Helsinki, Finland
  • Investigational Site 306 Helsinki, Finland
  • Investigational Site 302 Jarvenpaa, Finland
View all 33 locations
View Trial Details
Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers

NCT03205358

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Investigational Site Number 005 Espoo, Finland
  • Investigational Site Number 006 Helsinki, Finland
  • Investigational Site Number 002 Helsinki, Finland
  • Investigational Site Number 007 Jarvenpaa, Finland
View Trial Details
Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents

NCT02199691

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Birmingham, Alabama, United States
  • Huntsville, Alabama, United States
  • Downey, California, United States
  • San Diego, California, United States
View all 36 locations
View Trial Details
Completed

Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

NCT01900444

Conditions
Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Investigational Site 004 Gyeonggi-do, South Korea
  • Investigational Site 010 Gyeonggi-do, South Korea
  • Investigational Site 001 Seoul, South Korea
  • Investigational Site 005 Seoul, South Korea
View Trial Details

Related conditions